Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Emerging Team Grant: HIV/AIDS Vaccine Discovery & Social Research - LOI

University of British Columbia

$10,000.00

At the Crossroads of Vertical and Horizontal HIV Transmission: The HIV-Exposed Uninfected Infant as a Window into Successful HIV Vaccine Design

FY 2009-10

Summary
Over 2 million HIV exposed but uninfected newborns (HEU) are born every year. Most develop an immune response to HIV that remains detectable for years. This immune response is presumed to contribute to their protection from vertical HIV transmission around birth. But what role this immune response has on the risk for contracting HIV horizontally later in life has never been examined. We propose to develop and test strategies to reach HEU subjects in order to identify the prevalence of HIV infection in adolescent/adult HEU, and to initiate prospective studies aimed at identifying the responsible mechanisms (correlates of protection). As the maturation of the ongoing AIDS pandemic catapults this vulnerable age group into the spotlight in an era where the stigma associated with HIV still is overwhelming, developing effective and ethical tools to reach this population constitutes the necessary first step to not only extract guidelines for future vaccine design, but also to provide optimal care
Program
Emerging Team Grant: HIV/AIDS Vaccine Discovery & Social Research - LOI
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
188583
Name
Speert David P
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Emerging Team Grant : HIV/AIDS Vaccine Discovery and Social Research
Projecttitle
At the Crossroads of Vertical and Horizontal HIV Transmission: The HIV-Exposed Uninfected Infant as a Window into Successful HIV Vaccine Design
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Emerging Team Grant: HIV/AIDS Vaccine Discovery & Social Research - LOI
Keyworddelim
Adolescence; Cohort; Hiv; Immunity; Stigma; Vaccine
Abstract
Over 2 million HIV exposed but uninfected newborns (HEU) are born every year. Most develop an immune response to HIV that remains detectable for years. This immune response is presumed to contribute to their protection from vertical HIV transmission around birth. But what role this immune response has on the risk for contracting HIV horizontally later in life has never been examined. We propose to develop and test strategies to reach HEU subjects in order to identify the prevalence of HIV infection in adolescent/adult HEU, and to initiate prospective studies aimed at identifying the responsible mechanisms (correlates of protection). As the maturation of the ongoing AIDS pandemic catapults this vulnerable age group into the spotlight in an era where the stigma associated with HIV still is overwhelming, developing effective and ethical tools to reach this population constitutes the necessary first step to not only extract guidelines for future vaccine design, but also to provide optimal care
Competitiondate
200907
Approvedterm2
1 yr 0 mth
Pinamesdelim
Speert, David P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~